Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Nutrition in Acute Pancreatitis (OZT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03820128
Recruitment Status : Not yet recruiting
First Posted : January 29, 2019
Last Update Posted : January 29, 2019
Sponsor:
Information provided by (Responsible Party):
Medical University of Warsaw

Brief Summary:
The aim of the study is to assess the effect of the early oral refeeding and fat content in the diet on the length of stay, clinical course (included pain severity) in pediatric patients with mild and moderate AP. Patients will be randomized to groups: refeeding within 24 hours or after 24 hours from the hospital admission. Biochemical tests and pain severity will be evaluated.

Condition or disease Intervention/treatment Phase
Acute Pancreatitis Other: Early diet intervention Not Applicable

Detailed Description:
Prospective, randomized study. Research in the adult population shows that early enteral feeding in acute pancreatitis (AP) both oral and via the feeding tube is safe, shortens the length of hospital stay, prevents the multi organ failure (MoF) and reduces mortality. The pediatric population lacks prospective data concerning refeeding modes in AP. The aim of the study is to assess the effect of the early oral refeeding and fat content in the diet on the length of stay, clinical course (included pain severity) in pediatric patients with mild and moderate AP. Patients will be randomized to groups: refeeding within 24 hours or after 24 hours from the hospital admission. Biochemical tests including CRP, amylase, lipase and proinflammatory cytokines levels and zonulin level as well as severity of pain will be assessed again in the second, the third and the fifth hospital day.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 84 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Very Early and Early Nutrition in Acute Pancreatitis in Children: a Randomized Study
Estimated Study Start Date : February 1, 2019
Estimated Primary Completion Date : October 1, 2020
Estimated Study Completion Date : January 31, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pancreatitis

Arm Intervention/treatment
Active Comparator: Very early refeeding

Very early diet intervention: refeeding within 24 hours from the hospital admission.

Participants will be encouraged to start eating immediately after the time of admission. They will be able to choose the meal from the list with no amount or calories restriction.They will be asked to conduct the daily diet diary - time of feeding, quality and quantity of the foods ingested. Laboratory tests will be performed at the study entry, on the day of 3 and 5 of hospitalization and on the day of discharge.

Other: Early diet intervention
Participant's diet includes several low-fiber and low-fat commonly available meals and products. Patients will choose what they want to eat with no amount or calories restriction.

Active Comparator: Early refeeding

Early diet intervention: refeeding after 24 hours from the hospital admission .

During the first 24 hours after admission participants will be on fluid only (orally and/or intravenously). Later on they will be encouraged to start eating. They will be able to choose the meal from the list with no amount or calories restriction.They will be asked to conduct the daily diet diary - time of feeding, quality and quantity of the foods ingested. Laboratory tests will be performed at the study entry, on the day of 3 and 5 of hospitalization and on the day of discharge.

Other: Early diet intervention
Participant's diet includes several low-fiber and low-fat commonly available meals and products. Patients will choose what they want to eat with no amount or calories restriction.




Primary Outcome Measures :
  1. Length of hospitalization [ Time Frame: through study completion, an average of 2 years ]
    Number days of hospitalization


Secondary Outcome Measures :
  1. Time between the onset of symptoms and the first feeding [ Time Frame: assessed at the day of 2 ]
    Time between the onset of symptoms and the first feeding measured in hours

  2. Adverse events [ Time Frame: daily assessment in the first three days of hospitalization ]
    Severity of abdominal pain daily using a 10 point visual - analog scale (VAS). 0 means lack of the pain, 10 means the most severe pain

  3. Average calories intake [ Time Frame: through study completion, an average of 2 years ]
    Average calories intake (kcal)

  4. Levels of proinflammatory cytokine levels. [ Time Frame: through study completion, an average of 2 years ]
    Proinflammatory cytokine levels (ng/ml) using ELISA tests

  5. Zonulin level [ Time Frame: through study completion, an average of 2 years ]
    Zonulin level (ng/ml) using ELISA test



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Year to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • AP diagnosis according to the generally accepted criteria ie. fulfilling two out of three criteria:

    • Abdominal pain of pancreatic origin
    • Radiologic findings supportive of AP on imaging
    • Amylase or lipase levels elevation three times above the upper limit of normal
  • Mild or moderate AP Mild AP: AP without organ failure, local or general complications Moderate AP: AP that may be accompanied by intermittent organ failure, local complications or concomitant disease worsening
  • No contradictions to enteral treatment
  • Informed consent from the parents or legal guardian and from the patient if older than 16 years

Exclusion Criteria:

  • Severe general condition
  • Severe AP
  • Kidney insufficiency, cardiac insufficiency
  • Diabetes type 1
  • Cystic fibrosis
  • Contraindications to enteral feeding
  • Lack of required informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03820128


Contacts
Layout table for location contacts
Contact: Aleksandra Banaszkiewicz, Ass. Prof. 48 22 317 9451 abanaszkiewicz@wum.edu.pl

Locations
Layout table for location information
Poland
Departement of Paediatric Gastroenterology and Nutrition.
Warsaw, Poland, 02-091
Sponsors and Collaborators
Medical University of Warsaw
Layout table for additonal information
Responsible Party: Medical University of Warsaw
ClinicalTrials.gov Identifier: NCT03820128    
Other Study ID Numbers: OZT
First Posted: January 29, 2019    Key Record Dates
Last Update Posted: January 29, 2019
Last Verified: June 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pancreatitis
Pancreatic Diseases
Digestive System Diseases